PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label Eisai. Show all posts

Showing posts with label Eisai. Show all posts

EISAI COMPLETES ACQUISITION OF LIAONING TIANYI BIOLOGICAL PHARMACEUTICALS

Eisai Co Ltd announced that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical ...

EISAI TO PRESENT LATEST DATA ON FYCOMPA

Eisai Co., Ltd announced that the latest data on its in-house developed AMPA receptor antagonist Fycompa® (perampanel hydrate, “perampanel...

Results of PHASE III TRIAL OF ANTIEPILEPTIC DRUG PERAMPANEL

Eisai Co., Ltd announced today that an oral presentation highlighting results from a Phase III clinical study (Study 335) of its in-house ...

Eisai to Test Drug Candidate for Eumycetoma

The Drugs for Neglected Diseases initiative and the Japanese pharmaceutical company Eisai Co., Ltd. have signed an agreement to proceed wi...

View web version

Powered by Blogger.